The dawn of a new era in therapeutics

Casting light into the complex landscape of protein engineering and empowering human health.


From diabetes, to cancer, to genetic and chronic diseases, there’s a commonality within each that has impacted patients’ wellness: their treatments utilize protein therapeutics. BioHybrid Solutions’ world renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: How can we create longer-lived, more effective medicine?

While getting to an answer wasn’t simple, it has arrived. Our proprietary technology NanoArmors™ the surface of proteins, enabling them to work better in the human body.



Developed at Carnegie Mellon University, our next-generation NanoArmored™ protein-polymer conjugates with scalable capabilities perfectly suited for advanced therapeutics. We partner with organizations like the NSF, DEP, DoD and DTRA.


OPH Prophylactic

Customer & Partner: US Government ($35M DTRA program). This NanoArmored™ OPH beats PEGylated OPH for nerve agent prophylaxis. The program includes pre-clinical manufacturing and testing of NanoArmored™ drug.


GI Enzyme Replacement Therapy

A NanoArmored™ stomach-acid resistant oral enzyme replacement therapy (lipase, amylase, protease) with increased stability, lifetime and activity in the stomach and intestine. The market is expected to reach US$1.85 billion by 2023.


Enabling Immunotherapy Program

NanoArmored™ Therapeutic Proteins & Enzymes designed to help the body fight off cancer. This is currently in internal development with feasibility and pilot stages commencing in the first quarter of 2020.

NanoArmory™ Pipeline

Imagine a new alternative to PEGylation that enables more patient friendly routes of administration, reduced immunogenicity and improved pharmacodynamics and pharmacokinetics.


BioHybrid Solutions is a leading partner to significant federal agencies and foundations, including the U.S. Departments of Defense and Energy and the National Science Foundation. To date, we have created thousands of different NanoArmored™ proteins™ for a variety of therapeutic and industrial applications. Our proprietary technologies are currently being utilized to develop the next-generation of protein therapeutics that will meet the most critical needs for both civilian and military populations. Looking to partner with BHS? Contact us today. 

Discover a better solution For therapeutics and protein engineering